PR Newswire: New Data Show Long-Term Benefit of Transcranial Magnetic Stimulation
The American Psychiatric Association released new today today regarding the benefits of NeuroStar TMS Therapy for patients with Major Depressive Disorder. As covered in this new release from PR Newswire, at the end of short-term treatment, 62 percent of patients achieved improvement in symptoms while 41 percent reported full remission. A remarkable 68 percent of patients saw improvement in symptoms along with 45 percent reaching remission after long-term treatment.
The study, which included 42 clinical practices and 307 patients, examined the long-term effectiveness of NeuroStar TMS Therapy for the course of 52 weeks after an acute treatment path.
Learn more about the study and NeuroStar TMS Therapy here.